New IVF drug combo may boost baby chances
NCT ID NCT04064840
First seen May 15, 2026 · Last updated May 25, 2026 · Updated 2 times
Summary
This study tests if a hormone drug called GnRH agonist can improve live birth rates in women under 43 undergoing IVF or frozen embryo transfer. About 784 participants will receive either the GnRH agonist or a standard hormone trigger. The goal is to see if the new approach leads to more successful pregnancies and live births.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBFERTILITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Obstetrics and Gynaecology
RECRUITINGHong Kong, Hong Kong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.